2018 Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss

DUBLIN–(BUSINESS WIRE)–The “Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss” report has been added to ResearchAndMarkets.com’s offering.

“Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss”

Tweet this

This Genetic Technology TOE depicts life sciences trends across drug delivery platforms, cancer immunotherapies, biomarker identification, and gene therapy.

Among the therapeutic areas in focus, age-related macular degeneration (AMD), aggressive childhood cancers, and bladder cancer, are of note.

Clinical trial analysis of recombinant drugs for different forms of cancer is also presented.

Key Topics Covered

  1. Advancements in Mode of Drug Delivery for Age-related Macular Degeneration
  2. Immunotherapy Developments for Aggressive Childhood Cancers
  3. Novel Biomarkers for p53-like Subtype of Bladder Cancer
  4. Novel Gene Therapy Construct that Halts Vision Loss
  5. Clinical Trial Analysis of Recombinant Drugs for Different Forms of Cancer
  6. Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/3bvvvg/2018_innovations?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: GenomicsDrug DeliveryOncology DrugsBiomarkers

Source: Business Wire

On